Yahoo奇摩 網頁搜尋

搜尋結果

  1. Medications and prescription drug information for consumers and medical health professionals. Online database of the most popular drugs and their side effects, interactions, and use. Cuts, Scrapes, Wounds, Bruises, Burns Stratagraft (Allogeneic Cultured

    • General
    • Laboratory Tests
    • Carcinogenesis, Mutagenesis, Impairment of Fertility
    • Pregnancy
    • Pediatric Use
    • Geriatric Use

    Oral Fansidar (sulfadoxine and pyrimethamine) has not been evaluated for the treatment of cerebral malaria or other severe manifestations of complicated malaria, including hyperparasitemia, pulmonary edema or renal failure. Patients with severe malaria are not candidates for oral therapy. In the event of recrudescent P. falciparuminfections after t...

    Regularly scheduled complete blood counts, liver enzyme tests and analysis of urine for crystalluria should be performed whenever Fansidar (sulfadoxine and pyrimethamine) is administered for more than three months.

    Pyrimethamine was not found carcinogenic in female mice or in male and female rats. The carcinogenic potential of pyrimethamine in male mice could not be assessed from the study because of markedly reduced life-span. Pyrimethamine was found to be mutagenic in laboratory animals and also in human bone marrowfollowing 3 or 4 consecutive daily doses t...

    Fansidar (sulfadoxine and pyrimethamine) has been shown to be teratogenicin rats when given in weekly doses approximately 12 times the weekly human prophylactic dose. Teratology studies with pyrimethamine plus sulfadoxine (1:20) in rats showed the minimum oral teratogenic dose to be approximately 0.9 mg/kg pyrimethamine plus 18 mg/kg sulfadoxine. I...

    Fansidar (sulfadoxine and pyrimethamine) should not be given to infants less than 2 months of age because of inadequate development of the glucuronide-forming enzyme system.

    Clinical studies of Fansidar (sulfadoxine and pyrimethamine) did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an e...

  2. 2022年5月16日 · The dosing schedule was 1-2 drops per eye once in the morning on Days 1 and 16; 1-2 drops per eye every two hours Days 2 through 8; and 1-2 drops per eye every four hours Days 9 through 15. The mean levofloxacin concentration in plasma 1 hour post dose ranged from 3.13 ng/mL on Day 1 to 10.4 ng/mL on Day 16.

  3. 2023年2月13日 · drooping eyelids, trouble swallowing, vision changes, upper stomach pain, dark urine, and. yellowing of the skin or eyes ( jaundice) Get medical help right away, if you have any of the symptoms listed above. Common side effects of Ativan include: Drowsiness.

  4. 2022年9月22日 · Ella may cause serious side effects including: hives, difficulty breathing, swelling of your face, lips, tongue, or throat, and. severe pain in your lower stomach 3 to 5 weeks after using the medicine. Get medical help right away, if you have any of the symptoms listed above. The most common side effects of Ella are:

  5. 2022年9月20日 · Both neonates received 1.0 g of EMLA Cream. In patients treated with EMLA Cream on intact skin, local effects observed in the trials included: paleness (pallor or blanching) 37%, redness (erythema) 30%, alterations in temperature sensations 7%, edema 6%, itching 2% and rash, less than 1%.

  6. LINZESS contains linaclotide-coated beads in hard gelatin capsules. LINZESS is available as 72 mcg, 145 mcg and 290 mcg capsules for oral administration. The inactive ingredients of LINZESS 72 mcg capsules include: calcium chloride dihydrate, L-histidine, microcrystalline cellulose, polyvinyl alcohol, and talc.

  1. 其他人也搜尋了